Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
38.31 USD | +2.08% | +7.14% | -43.19% |
Feb. 20 | Medifast, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Feb. 20 | Transcript : Medifast, Inc., Q4 2023 Earnings Call, Feb 20, 2024 |
Chart calendar Medifast, Inc.
Upcoming events on Medifast, Inc.
Past events on Medifast, Inc.
2024-02-20 04:30 pm | Q4 2023 Earnings Call |
2024-02-20 04:05 pm | Q4 2023 Earnings Release |
2023-12-13 10:00 am | Medifast, Inc and LifeMD, Inc Collaboration Agreement Call |
2023-11-06 04:30 pm | Q3 2023 Earnings Call |
2023-11-06 04:05 pm | Q3 2023 Earnings Release |
2023-09-17 | Ex-dividend day |
2023-08-07 04:30 pm | Q2 2023 Earnings Call |
2023-08-07 04:05 pm | Q2 2023 Earnings Release |
2023-06-25 | Ex-dividend day |
2023-06-14 04:30 pm | Annual General Meeting |
2023-05-01 04:30 pm | Q1 2023 Earnings Call |
2023-05-01 04:05 pm | Q1 2023 Earnings Release |
2023-03-26 | Ex-dividend day |
2023-02-21 04:30 pm | FY 2022 Earnings Call |
2023-02-21 04:05 pm | FY 2022 Earnings Release |
2022-12-18 | Ex-dividend day |
2022-11-03 04:30 pm | Q3 2022 Earnings Call |
2022-11-03 04:05 pm | Q3 2022 Earnings Release |
2022-09-18 | Ex-dividend day |
2022-09-12 09:00 am | Jefferies Fitness & Wellness Summit |
Past dividends on Medifast, Inc.
2023-09-17 | Quarterly 1.65 USD |
2023-06-25 | Quarterly 1.65 USD |
2023-03-26 | Quarterly 1.65 USD |
2022-12-18 | Quarterly 1.64 USD |
2022-09-18 | Quarterly 1.64 USD |
2022-06-26 | Quarterly 1.64 USD |
2022-03-27 | Quarterly 1.64 USD |
2021-12-19 | Quarterly 1.42 USD |
2021-09-19 | Quarterly 1.42 USD |
2021-06-20 | Quarterly 1.42 USD |
Annual results
Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 714 705 1.23% | 935 917 1.89% | 1 526 1 524 0.13% | 1 599 1 591 0.45% | 1 072 1 065 0.64% | 694 |
EBITDA Million USD | Released Forecast Spread | 95,7 94,3 1.45% | 148 146 1.92% | 223 227 -1.55% | 227 215 5.81% | 147 151 -2.61% | 44,1 |
EBIT Million USD | Released Forecast Spread | 91,0 89,0 2.29% | 141 139 1.27% | 216 211 2.51% | 216 195 10.54% | 134 130 3.08% | 23,1 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 92,4 90,4 2.17% | 134 133 1.2% | 216 211 2.51% | 184 195 -5.42% | 129 132 -2.32% | 27,1 |
Net income Million USD | Released Forecast Spread | 77,9 71,0 9.74% | 103 103 -0.05% | 164 161 1.71% | 144 142 1.46% | 99,4 104 -4.36% | 20,9 |
EPS USD | Released Forecast Spread | 6,43 5,84 10.1% | 8,68 8,69 -0.08% | 13,9 13,6 1.88% | 12,7 12,5 1.52% | 9,10 9,52 -4.41% | 1,91 |
Announcement Date | 26/02/20 | 25/02/21 | 23/02/22 | 21/02/23 | 20/02/24 | - |
Quarterly results
Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 378 376 0.54% | 418 403 3.56% | 453 448 1.22% | 390 349 11.77% | 337 330 2.16% | 349 320 9.23% | 296 270 9.62% | 236 232 1.62% | 191 184 3.73% | 169 | 175 | 176 | 174 | 177 |
EBITDA Million USD | Released Forecast Spread | 46,4 45,4 2.15% | 57,5 58,6 -1.74% | 61,1 54,0 13.19% | 52,1 33,3 56.44% | 56,2 35,6 57.92% | 64,5 40,7 58.45% | 42,1 26,9 56.41% | 28,9 20,6 40.39% | 19,6 17,8 10.02% | 13,8 | 14,3 | 9,45 | 6,45 | 13,9 |
EBIT Million USD | Released Forecast Spread | 46,8 41,5 12.74% | 55,1 55,6 -0.86% | 58,4 49,4 18.2% | 49,2 28,2 74.62% | 53,3 32,7 62.89% | 53,5 35,8 49.47% | 38,7 21,1 83.44% | 25,5 15,4 66.18% | 16,2 12,2 33.04% | 10,3 | 8,50 | 3,55 | 0,75 | 10,2 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 46,8 41,5 12.7% | 55,0 55,6 -1.06% | 48,8 49,4 -1.15% | 47,9 27,9 71.61% | 32,4 32,4 0.02% | 53,3 35,6 49.8% | 39,1 20,9 87.16% | 26,5 15,5 71.28% | 9,80 12,9 -23.72% | 11,1 | 9,50 | 4,65 | 1,80 | 11,2 |
Net income Million USD | Released Forecast Spread | 34,0 31,3 8.8% | 41,8 41,8 -0.13% | 39,1 37,2 5.25% | 36,2 21,1 71.35% | 26,5 24,5 8.24% | 40,0 26,4 51.39% | 30,3 15,7 92.87% | 23,1 11,7 98.55% | 6,04 10,6 -42.79% | 8,55 | 7,30 | 3,55 | 1,40 | 8,60 |
EPS USD | Released Forecast Spread | 2,91 2,65 9.67% | 3,59 3,57 0.56% | 3,42 3,23 5.77% | 3,27 1,91 71.2% | 2,41 2,22 8.56% | 3,67 2,40 52.92% | 2,77 1,44 92.36% | 2,12 1,07 99.06% | 0,55 0,96 -42.71% | 0,78 | 0,67 | 0,33 | 0,13 | 0,79 |
Announcement Date | 23/02/22 | 02/05/22 | 03/08/22 | 03/11/22 | 21/02/23 | 01/05/23 | 07/08/23 | 06/11/23 | 20/02/24 | - | - | - | - | - |
Past sector events for Medifast, Inc.
2024-03-18 | BYHEALTH CO., LTD: Q4 2023 Earnings Release |
2024-03-18 | CK LIFE SCIENCES INT'L., (HOLDINGS) INC.: Q4 2023 Earnings Release |
2024-03-14 | CSPC INNOVATION PHARMACEUTICAL CO., LTD.: Q4 2023 Earnings Release |
2024-03-13 04:15 pm | JAMIESON WELLNESS INC.: Q4 2023 Earnings Release |
2024-02-27 01:32 am | GRAPE KING BIO LTD: Q4 2023 Earnings Release |
2024-02-20 04:05 pm | MEDIFAST, INC.: Q4 2023 Earnings Release |
2024-02-15 01:30 am | GRAPE KING BIO LTD: January 2024 Sales and Revenue Release |
2024-02-14 04:24 pm | HERBALIFE LTD.: Q4 2023 Earnings Release |
2024-02-13 | EUGLENA CO., LTD.: Q4 2023 Earnings Release |
2024-02-13 | EUGLENA CO., LTD.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock
- Equities
- Stock Medifast, Inc. - Nyse
- Calendar Medifast, Inc.